Showing results (871-880 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|April 30, 2016
Bioavailability of valsartan oral dosage formsGangadhar Sunkara, Girish Bende, Anisha E Mendonza, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjectsJoan M Korth-Bradley, Virginia Parks, Frank Wagner, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Evaluation of the effect of mericitabine at projected therapeutic and supratherapeutic doses on cardiac repolarization in healthy subjects: A thorough QT/QTc studyYa-Chi Chen, Joshua Haznedar, Rohit Kulkarni, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
The pharmacokinetics of darexaban (YM150), an oral direct factor Xa inhibitor, are not affected by ketoconazole, a strong inhibitor of CYP3A and P-glycoproteinDorien Groenendaal, Gregory Strabach, Alberto Garcia-Hernandez, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjectsTeddy Kosoglou, James Hubbell, Bhavna Kantesaria, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
A Phase I cardiac safety and pharmacokinetic study of tivozanib hydrochloride in patients with advanced solid tumorsKathleen Moore, Jeffrey R Infante, Monette M Cotreau, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Pharmacokinetics and safety of teneligliptin in subjects with hepatic impairmentAtef Halabi, Haidar Maatouk, Karl Ernst Siegler, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
A food effect study and dose proportionality study to assess the pharmacokinetics and safety of bardoxolone methyl in healthy volunteersNathan S Teuscher, Richard J Kelley, Emily O Dumas, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Statistical analysis of Amenamevir (ASP2151) between pharmacokinetics and clinical efficacies with non-linear effect model for the treatment of genital herpesAkitsugu Takada, Masataka Katashima, Atsunori Kaibara, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Effect of carbamazepine on the pharmacokinetics of paliperidone extended-release tablets at steady-stateVirginie Kerbusch-Herben, Adriaan Cleton, Joris Berwaerts, et al.
Pageof 136